Target intelligence / Profile preview

Corneal wound healing

Molecular classification
Other
01

Overview

Corneal wound healing is a highly orchestrated physiological response that restores the integrity and transparency of the cornea after injury, infection, or surgery. The process is characterized by distinct yet overlapping phases, including epithelial healing, stromal remodeling, and nerve regeneration. Epithelial healing involves the rapid migration and proliferation of limbal-derived epithelial cells to close surface defects, while stromal healing involves the activation of resident keratocytes into fibroblasts and myofibroblasts, which can lead to corneal scarring (haze) if the response is dysregulated. Therapeutic management of this process involves various agents such as lubricants, growth factors like nerve growth factor (Cenegermin), and anti-inflammatory medications to promote re-epithelialization and prevent permanent vision loss from fibrosis or neovascularization. Failure of this process can result in chronic complications like neurotrophic keratitis, persistent epithelial defects, or corneal opacification.

Other names
Corneal healing processCorneal repairCorneal epithelial wound healingCorneal regenerationCorneal stromal repair
02

Mechanism of action

Modulation of growth factor signaling pathways (e.g., NGF, EGF receptors), inhibition of matrix metalloproteinases (MMPs) to stabilize the extracellular matrix, and reduction of inflammatory cytokine production to promote epithelial closure and minimize stromal fibrosis.

03

Biological functions

Cell migrationCell proliferationTissue remodelingApoptosisExtracellular matrix organizationSignal transduction
04

Disease associations

Corneal ulcerNeurotrophic keratitisKeratitisCorneal opacityChemical burnDry eye disease
05

Safety considerations

Permanent corneal scarring (fibrosis)Corneal neovascularizationPersistent epithelial defects (PED)Risk of corneal melting (keratolysis) associated with excessive corticosteroid useSecondary infection during delayed healing
06

Interacting drugs

Cenegermin

5 more in the full profile.

07

Biomarkers

Matrix metalloproteinase-9 (MMP-9)Corneal epithelial defect size (fluorescein staining area)Corneal sensitivity (esthesiometry)Pro-inflammatory cytokines (e.g., Interleukin-1, Tumor Necrosis Factor-alpha)

Beyond the preview

Go deeper on Corneal wound healing.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corneal wound healing.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call